Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease
Clinical trial NCT02378701 · COMPLETED
Trial details
- NCT number
- NCT02378701
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-02-01
- Primary completion
- 2022-07-18
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.